- Full text PDF available (1)
- This year (4)
- Last 5 years (13)
- Last 10 years (13)
Journals and Conferences
The management of heart failure with reduced ejection fraction (HF-REF) has improved significantly over the last two decades. In contrast, little or no progress has been made in identifying… (More)
BACKGROUND Although cardiac contractility modulation (CCM) has emerged as a promising device treatment for heart failure (HF), the effect of CCM on functional capacity and quality of life has not… (More)
The most recent heart failure (HF) guidelines of the Heart Failure Association of the European Society of Cardiology, published in mid-2016, include a significantly expanded section on HF with… (More)
Introduction to a special supplement issue on the importance of uric acid in cardiovascular disorders.
It was very heartening to see such a good review of animalmodels of cardiac cachexia. It is surprising how long this common and debilitating complication of end stage heart disease has languished… (More)
Chronic heart failure (CHF) is a syndrome consisting of alterations of cardiac function associated with an array of abnormalities of haemodynamic, neuroendocrine, autonomic, and vascular function and… (More)
INTRODUCTION We compared the frequency of cancer, heart and lung related cachexia and cachexia-related research articles in the specialist journal, Journal of Cachexia, Sarcopenia and Muscle (JCSM)… (More)
Heart failure has reached epidemic proportions given the ageing of populations and is associated with high mortality and re-hospitalization rates. This article reviews and summarizes recent advances… (More)
The accompanying special issue reviews the role of eplerenone and spironolactone in the management of various cardiovascular and renal conditions.